ResearcherUniversitätsmedizin GöttingenActive in the last 2 years

Maj-Britt Paulsohn

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-5625-7251; OpenAlex author ID A5115875331. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2025: 1 paper

Papers 1

Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cells. Co-author DOI 10.1038/s41419-025-08362-w ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Adi Danieli‐Mackay · 1 shared paper, 2025 · strength 0.21
- Paper Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cells. DOI 10.1038/s41419-025-08362-w ↗
Gabriela Salinas Riester · 1 shared paper, 2025 · strength 0.21
- Paper Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cells. DOI 10.1038/s41419-025-08362-w ↗
Constanza Tapia Contreras · 1 shared paper, 2025 · strength 0.21
- Paper Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cells. DOI 10.1038/s41419-025-08362-w ↗
Carolin Schneider · 1 shared paper, 2025 · strength 0.21
- Paper Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cells. DOI 10.1038/s41419-025-08362-w ↗
Günter Schneider · 1 shared paper, 2025 · strength 0.21
- Paper Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cells. DOI 10.1038/s41419-025-08362-w ↗
Elisabeth Heßmann · 1 shared paper, 2025 · strength 0.21
- Paper Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cells. DOI 10.1038/s41419-025-08362-w ↗
Matthias Dobbelstein · 1 shared paper, 2025 · strength 0.21
- Paper Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cells. DOI 10.1038/s41419-025-08362-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.